Sanofi Can't Enforce Deal It Broke In $20M Suit, Elorac Says
The maker of a cream used to treat osteoarthritis hit back at Sanofi-Aventis Canada Inc.'s claims its contract to market the cream is void, arguing Thursday that it was Sanofi who...To view the full article, register now.
Already a subscriber? Click here to view full article